Protective strategies against ischemic injury of the liver.
about
Pharmacological interventions to decrease ischaemia reperfusion injury in liver transplantationPharmacological interventions to reduce ischaemia-reperfusion injury for liver resections performed under vascular controlN-acetylcysteine -- passe-partout or much ado about nothing?Ischemia reperfusion-facilitated sinusoidal endothelial cell injury in liver transplantation and the resulting impact of extravasated platelet aggregationMitochondrial Dysfunction and Autophagy in Hepatic Ischemia/Reperfusion InjuryPharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell PhenotypeThe role of neutrophils in the development of liver diseasesPolyethylene Glycol Preconditioning: An Effective Strategy to Prevent Liver Ischemia Reperfusion Injury.Ischemic preconditioning impairs liver regeneration in extended reduced-size livers.Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang.SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by alpha-lipoic acid in humans.Liver graft exposure to carbon monoxide during cold storage protects sinusoidal endothelial cells and ameliorates reperfusion injury in rats.Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury.Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse.Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: impact on ischaemia-reperfusion injury and clinical relevance.Resuscitation of ischemic donor livers with normothermic machine perfusion: a metabolic flux analysis of treatment in rats.Biliverdin protects against liver ischemia reperfusion injury in swine.The protective effect of diosmin on hepatic ischemia reperfusion injury: an experimental study.The effects of low-intensity laser therapy on hepatic ischemia-reperfusion injury in a rat model.Remote ischemic preconditioning protects against liver ischemia-reperfusion injury via heme oxygenase-1-induced autophagyBH3-only proteins contribute to steatotic liver ischemia-reperfusion injury.A systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation.Ischaemic preconditioning: therapeutic implications for stroke?Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouseEpigallocatechin gallate induces expression of heme oxygenase-1 in endothelial cells via p38 MAPK and Nrf-2 that suppresses proinflammatory actions of TNF-αThe role of pharmacogenomics in the prediction of efficacy of anti-TNF therapy in patients with Crohn's disease.Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron.The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models.Mesenchymal Stromal Cell-Derived Factors Promote Tissue Repair in a Small-for-Size Ischemic Liver Model but Do Not Protect against Early Effects of Ischemia and Reperfusion Injury.Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis.TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.Preserving low perfusion during surgical liver blood inflow control prevents hepatic microcirculatory dysfunction and irreversible hepatocyte injury in rats.Calcium/calmodulin-dependent protein kinase IV limits organ damage in hepatic ischemia-reperfusion injury through induction of autophagy.Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resectionAnti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liverCardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning.Fibronectin-α4β1 interactions in hepatic cold ischemia and reperfusion injury: regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway.In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.
P2860
Q24240158-FC066B53-4D04-4953-BFF6-2C08F1812990Q24241861-EA2A7005-C5EF-4758-AEF4-C036BA15AAE9Q24678741-56360204-D4C5-45D6-B467-B2B8BD711551Q26750681-F6841FD0-48B8-4BD9-82E3-08C5E93D7B45Q26771761-5C470998-483E-41C2-8AAD-B15E85477119Q26779198-1CA9B3C1-6BD3-40F4-93D0-727B8B6DB727Q26864040-41AC1F31-684C-471E-B4F5-13498650A84CQ27348973-7B3F32CF-02A7-4098-B059-A924EF20B509Q33212247-EBB507B0-23D0-4ED2-8C72-89FBDF508EC3Q33217692-6E48C41B-B242-4FD0-802E-0BC369A1CE3FQ33756417-86384917-9C0E-4D5D-8C8F-2BA21EC138B9Q33865021-909E5526-901F-41EE-8E0A-1210B7ABE83EQ33866307-A11BF585-A20B-420E-8C00-0E846045DE34Q34093374-2C38ADD4-B8D4-487D-B780-8D373641DAF0Q34401648-2530F0D9-2E8A-4EC5-AE23-11FF46B54C05Q34446369-FFA679C8-9154-4563-9A49-D2620C03F9F9Q34538821-E9143BB1-3CEC-41AD-8E75-9E49F1832BA4Q34903798-1E8CFF90-9D1E-49EC-AB7E-8BD66E90FE18Q34905192-18835DBB-8A27-406E-B6A2-18D6A4BEDD88Q35099997-9D2701C8-340E-4053-AC08-4817AC8063F1Q35183170-084003C2-D370-46A7-98B4-79A18EF330C3Q35184610-BE22DC20-C3E2-4C70-91D8-9072E817BC01Q35206142-CB64816F-EA96-41B6-9336-1028D758AD16Q35616460-3A516A9A-0093-4DA3-B346-29FB9A4D1D32Q35753366-FF82CAA3-D095-4C76-B7A9-39C7A9D603AFQ35761225-A5AD9B83-02F1-4234-9CCC-56FF64C46CDBQ35812610-30F21D62-F9F3-40E3-AF36-B53D56FBADC3Q35814374-288072DF-DC8E-417C-AB43-FADBD6B6B58DQ35937722-A616F69E-52D2-478C-9974-2202AE0E6CE5Q35977888-31A68F08-2E94-45E9-8721-701201579379Q36031956-B3C3B77D-0D97-4F15-9ECD-6896EFD5D1FAQ36065737-9631F99F-0043-42F9-9991-047FA21728ABQ36067201-BD15A822-0416-4A82-995B-55703BA494B3Q36099821-2AE9059F-2AE0-40DB-A654-1011749E1F94Q36114899-AD3A59EF-B3F5-4649-A3E3-50D2BC9DD221Q36116967-5A1C1899-E2F4-46E9-AC74-00CB04817E9DQ36146299-22BB7F7A-60E9-4EFA-AA53-5EFE48B92818Q36228179-81A3B980-006C-4391-AFF7-7E55711E8E18Q36282336-B6E75E0D-EB8F-4E9B-89D6-1102666513F9Q36377291-E21AE1AE-5F37-45FD-80A5-23F2D80E93E4
P2860
Protective strategies against ischemic injury of the liver.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Protective strategies against ischemic injury of the liver.
@ast
Protective strategies against ischemic injury of the liver.
@en
type
label
Protective strategies against ischemic injury of the liver.
@ast
Protective strategies against ischemic injury of the liver.
@en
prefLabel
Protective strategies against ischemic injury of the liver.
@ast
Protective strategies against ischemic injury of the liver.
@en
P1433
P1476
Protective strategies against ischemic injury of the liver.
@en
P2093
Hannes Rudiger
Nazia Selzner
P304
P356
10.1016/S0016-5085(03)01048-5
P407
P577
2003-09-01T00:00:00Z